StockData
ODYYOTCSurgical & Medical Instruments & ApparatusFiscal year ends July 31

Odyssey Health, Inc.

Financials through Q3 FY2026, quarter ended Apr 30, 2026Last filing: 10-Q on Jun 12, 2026
$0.01−0.00 (-16.25%)

Close on Oct 19, 2026

Market cap
$1.25M
P/E (TTM)
–
Dividend yield
–

About Odyssey Health

Surgical & Medical Instruments & Apparatus, SIC 3841

Odyssey Health, Inc. is a medical device development company focused on acquiring, developing, and commercializing medical technologies and products. The company operates through a single business segment and concentrates on two development-stage technologies: the CardioMap system, an electrocardiogram heart monitoring and screening device for detecting coronary heart disease, and the Save-A-Life choking rescue device, designed to remove airway obstructions. The company plans to license its proprietary technologies, partner with third-party manufacturers and distributors, and directly market products to healthcare providers, cardiologists, emergency facilities, hospitals, clinics, and consumers.

The company operates with two employees and conducts research and development activities in the United States while pursuing international distribution and licensing opportunities. Its principal executive offices and corporate headquarters are located in Las Vegas, Nevada. As a development-stage business, the company currently maintains no commercial operations or physical store network, and neither of its primary product candidates has received regulatory clearance for commercial distribution.

Summary of the business section of Odyssey Health's latest annual report, written by StockData.

Company profile

Company

Legal name
Odyssey Health, Inc.
Founded
2014
Headquarters
Las Vegas, NV
Address
2300 West Sahara Avenue, Suite 800-#4012 89102
Phone
(702) 780-6559
Employees
2, Jul 31, 2025
Industry
Surgical & Medical Instruments & Apparatus
Incorporated in
Nevada
Fiscal year ends
July 31
Auditor
Turner, Stone & Company, L.L.P., Dallas, Texas

Stock & identifiers

Ticker
ODYY
Exchange
OTC
Shares outstanding
101M, Jun 12, 2026
Public float
$1.77M, Jan 31, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
SEC CIK
1626644
EIN
47-1022125

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

No recent ownership filings by officers or directors

Odyssey Health's leadership is listed in its proxy statement, last filed Oct 30, 2023.

Employees

Headcount reported in annual reports

“At the date hereof, we have two employees and do not intend to hire additional employees in the foreseeable future.”

Corporate history

Events identified from SEC filings

DateEventDetails
Oct 30, 2024Late filingNotification of late filing
Mar 18, 2024Late filingNotification of late filing
Dec 29, 2023Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Feb 18, 2022Name changeName changed from Odyssey Group International, Inc. to Odyssey Health, Inc.
Jun 14, 2021Late filingNotification of late filing
Oct 29, 2020Late filingNotification of late filing
Oct 27, 2020Auditor changeChange in certifying accountant (8-K Item 4.01)
Aug 6, 2020Auditor changeChange in certifying accountant (8-K Item 4.01)
Oct 29, 2018Late filingNotification of late filing
Jun 13, 2018Late filingNotification of late filing
Mar 21, 2018Late filingNotification of late filing
Dec 12, 2017Late filingNotification of late filing
Oct 30, 2017Late filingNotification of late filing
Jun 14, 2017Late filingNotification of late filing
Mar 14, 2017Late filingNotification of late filing
Dec 13, 2016Late filingNotification of late filing
Nov 1, 2016Late filingNotification of late filing
Jun 14, 2016Late filingNotification of late filing
Dec 15, 2015Late filingNotification of late filing